Health Care • Medical/Dental Instruments
$237.60 ▼ -4.88
(-2.01%)
MKT CAP: $14.35B • VOL: 2.07M
52W L $81 52W H $249
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$200
MEDIAN
$266
MEAN
$271
HIGH
$323
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE GKOS TAPE
GKOS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $287.50 | $273.24 | 2025-02-14 | $216.22 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $299.38 | $280.37 | 2025-02-06 | $223.34 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $270.86 | $261.36 | 2025-01-29 | $228.10 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $242.35 | — | 2025-01-17 | $232.85 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $209.09 | $225.72 | 2025-01-09 | $211.46 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $282.74 | $247.10 | 2024-12-18 | $206.71 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $230.47 | $239.98 | 2024-12-04 | $220.97 | -4.3% | 48% | C |